Long-Term ISMN/I- and INcald/I-ASO Combinatorial Therapy in SMA Mice and INCALD/I-ASO Treatment in h...
Long-Term ISMN/I- and INcald/I-ASO Combinatorial Therapy in SMA Mice and INCALD/I-ASO Treatment in hiPSC-Derived Motor Neurons Show Protective Effects
About this item
Full title
Author / Creator
Publisher
MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
MDPI AG
Subjects
More information
Scope and Contents
Contents
For SMA patients with only two SMN2 copies, available therapies might be insufficient to counteract lifelong motor neuron (MN) dysfunction. Therefore, additional SMN-independent compounds, supporting SMN-dependent therapies, might be beneficial. Neurocalcin delta (NCALD) reduction, an SMA protective genetic modifier, ameliorates SMA across species....
Alternative Titles
Full title
Long-Term ISMN/I- and INcald/I-ASO Combinatorial Therapy in SMA Mice and INCALD/I-ASO Treatment in hiPSC-Derived Motor Neurons Show Protective Effects
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracacademiconefile_A751925206
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A751925206
Other Identifiers
ISSN
1422-0067
DOI
10.3390/ijms24044198
